Institutional Ownership Tc Biopharm Hldgs PLC Wt Pur S (TCBPW)
This table provides information about the institutional ownership of Tc Biopharm Hldgs PLC Wt Pur S (TCBPW). We have compiled data on the 8 institutions that hold shares in the stock, with a total of 4.22 Million shares, which have been reported (via 13F filing form) to have a value of $84,000.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Empery Asset Management, LP
New York, NY |
Nov 14, 2022 Q3 2022 |
2,823,528
shares
|
$56,470
3.89% of portfolio
|
Q1 2022
New holding
|
|
|
Wolverine Asset Management LLC
|
Feb 03, 2025 Q4 2024 |
668,324
shares
|
$13,366
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Kepos Capital LP
New York, NY |
Feb 11, 2025 Q4 2024 |
470,588
shares
|
$9,411
0.0% of portfolio
|
Q1 2022
New holding
|
|
|
Nantahala Capital Management, LLC
New Canaan, CT |
Feb 14, 2025 Q4 2024 |
235,294
shares
|
$4,705
0.0% of portfolio
|
Q1 2022
New holding
|
|
|
Csenge Advisory Group
|
Jan 30, 2025 Q4 2024 |
23,862
shares
|
$477
0.0% of portfolio
|
Q4 2024
Added 26.51%
|
|
|
Ubs Group Ag
|
Feb 14, 2025 Q4 2024 |
2,400
shares
|
$48
0.0% of portfolio
|
Q4 2024
Added 103.22%
|
|
|
Armistice Capital, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
188
shares
|
$3
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Feb 13, 2025 Q4 2024 |
0
shares
|
$0
0.0% of portfolio
|
Q4 2024
New holding
|